Why SARS-CoV-2 bounces back after antiviral treatment
The antiviral combination of nirmatrelvir and ritonavir (brand name Paxlovid) is an effective treatment for people with COVID ...
pulmonologyadvisor4d
COVID Antiviral, mAb Treatments Reduce Mortality and Hospitalization Rates
Certain antiviral and mAb therapies were shown to lower mortality and hospitalization rates in those infected with SARS-CoV-2 Omicron variants.
Hosted on MSN1mon
Extended Nirmatrelvir/Ritonavir Beneficial for Some With Long COVID
WEDNESDAY, Jan. 8, 2025 (HealthDay News) -- Extended-course nirmatrelvir/ritonavir yields a meaningful reduction in symptoms for some patients with long COVID, but not all benefits persist ...
News Medical on MSN7d
In silico docking of clinically approved drugs against the SARS-CoV-2 receptor-binding domain
Announcing a new article publication for BIO Integration journal. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first identified in China in December 2019, rapidly spread worldwide, ...
AlphaGalileo10d
Lopinavir and Ritonavir have High Affinity Toward the SARS-CoV-2 S-protein Receptor-binding Domain Sequenced in Brazil
Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.